Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1120-1123

  Oertel, Stephan H ^a   Anagnostopoulos, Ioannis ^b   Hummel, Manfred W ^c   Jonas, Sven ^a   Riess, Hanno B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Antiviral treatment; Epstein Barr virus; Foscarnet; Post transplant lymphoproliferative disorder; Transplantation

Indexed keywords

ANTIVIRUS AGENT; FOSCARNET; IMMEDIATE EARLY PROTEIN BZLF1; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; EPSTEIN BARR VIRUS; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOLOGY; KIDNEY TRANSPLANTATION; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; REMISSION; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; ANTIVIRAL AGENTS; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS INFECTIONS; FOSCARNET; GENE REARRANGEMENT; HEART TRANSPLANTATION; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY TRANSPLANTATION; LYMPHOMA, B-CELL; MALE; POSTOPERATIVE COMPLICATIONS; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 0036050827     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03764.x     Document Type: Article

References (12)

1. Iatrogenic lymphoproliferative disorders in nontransplantational settings
2. Correlative morphologic and molecular genetic analysis demonstrate three distinct categories of posttransplantation lymphoproliferative disorders
3. Identification of an Epstein-Barr virus-coded thymidine kinase
4. Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr virus-associated lymphoma
5. Antiviral effects of phosphonoformate
6. Immunosurveillance, immunodeficiency and lymphoproliferations
7. Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation
8. Virostatic therapy for advanced lymphoproliferation associated with the Epstein-Barr virus in an HIV-infected patient
9. Regression of Epstein-Barr virus associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet
10. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy
11. Epstein-Barr virus and lymphoproliferation in methotrexate treated rheumatoid arthritis
12. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease